首页> 外文学位 >Mammary gland involution as a target for pregnancy-associated breast cancer prevention: Insights from NSAIDs and macrophages.
【24h】

Mammary gland involution as a target for pregnancy-associated breast cancer prevention: Insights from NSAIDs and macrophages.

机译:乳腺退化作为预防与妊娠有关的乳腺癌的目标:NSAID和巨噬细胞的见解。

获取原文
获取原文并翻译 | 示例

摘要

Pregnancy-associated breast cancer (PABC) is diagnosed within 5-10 years postpartum, and has poor prognosis. Involution, the post-partum remodeling of the mammary gland, engages physiologic programs characteristic of wound-healing and inflammation known to be tumor promotional. Our involution-hypothesis predicts cancerous lesions exposed to the involuting microenvironment are likely to metastasize. Further, treatment targeting the inflammatory attributes of involution may decrease progression of PABC. Previous work demonstrates mammary extracellular matrix (ECM) from involuting glands promotes metastasis in a xenograft model, while nulliparous-ECM does not. To address whether systemic non-steroidal anti-inflammatory drugs (NSAIDs) administered during post-partum involution decrease the tumor promotional characteristics of mammary involution-ECM, ECM from NSAID treated rats was used as substrata for breast epithelial cells in 3D-culture assays. The organization of non-transformed and tumorigenic mammary cells in the 'NSAID-ECM' phenocopied the response of cells cultured in tumor suppressive nulliparous-ECM. Importantly, NSAID use during involution did not interrupt mammary epithelial cell regression critical to gland remodeling. In a PABC mouse model, the involution-microenvironment promoted tumor size, tumor cell COX-2 expression, and tumor cell escape to the lung, all of which were suppressed by ibuprofen treatment during involution. These data confirm the tumor promotional microenvironment of mammary involution can be targeted with NSAIDs. One potential specific target in the involuting microenvironment is the macrophage, an immune cell that promotes mammary cancer metastasis in mice and is associated with negative outcomes for breast cancer patients. IHC and cytokine analyses revealed an increase in tumor promotional M2-macrophages during mammary involution in rodents. Involution-specific increases in monocyte chemotactic protein and fibrillar collagen proteolysis were identified as potential mediators of macrophage recruitment. Conditional depletion of macrophages (i.e. cells expressing CSF-1R) in Mafia mice resulted in delayed involution characterized by decreases in mammary epithelial cell apoptosis, alveolar regression, and adipocyte repopulation. These data suggest macrophages are necessary for involution. Investigation into the effect of directing involution M2 macrophages to the tumoricidal M1-type remains intriguing for a prevention strategy. Altogether this work reveals plausible targets for prevention of PABC progression in the mammary involution microenvironment, with implications for improving outcomes for thousands of young women with breast cancer.
机译:妊娠相关的乳腺癌(PABC)在产后5-10年内被诊断出,并且预后不良。退化是乳腺的产后重塑,它参与了伤口愈合和炎症特征性的生理程序,这些程序被认为是促进肿瘤的。我们的进化假设假设预测,在渐进的微环境中暴露的癌变可能会转移。此外,针对退化的炎症特性的治疗可降低PABC的进展。先前的研究表明,来自异化腺体的乳腺细胞外基质(ECM)在异种移植模型中促进了转移,而未产妇ECM则没有。为了解决产后复旧过程中使用的全身性非甾体抗炎药(NSAIDs)是否能降低乳腺复旧-ECM的肿瘤促进特性,在3D培养法中,将NSAID处理的大鼠的ECM用作乳腺上皮细胞的基质。 “ NSAID-ECM”表型中非转化和致瘤性乳腺细胞的组织表型化了在肿瘤抑制性未产卵性ECM中培养的细胞的反应。重要的是,在复旧过程中使用NSAID不会中断对腺体重塑至关重要的乳腺上皮细胞退化。在PABC小鼠模型中,对合微环境促进了肿瘤的大小,肿瘤细胞COX-2的表达以及肿瘤细胞向肺的逸出,所有这些都在对合过程中被布洛芬治疗所抑制。这些数据证实了NSAIDs可以靶向乳腺肿瘤的肿瘤促进微环境。渐进微环境中的一个潜在的特异性靶标是巨噬细胞,它是一种免疫细胞,可促进小鼠的乳癌转移,并与乳腺癌患者的阴性结果相关。 IHC和细胞因子分析表明,在啮齿类动物的乳房退化过程中,肿瘤促进性M2巨噬细胞增加。单核细胞趋化蛋白和原纤维胶原蛋白蛋白水解的向内特异性增加被认为是巨噬细胞募集的潜在介质。黑手党小鼠中巨噬细胞(即表达CSF-1R的细胞)的条件性耗竭导致复活延迟,其特征是乳腺上皮细胞凋亡,肺泡消退和脂肪细胞重新分布减少。这些数据表明巨噬细胞是内卷化所必需的。关于将对合M2巨噬细胞导向杀肿瘤M1型的效果的研究仍然吸引着预防策略。总的来说,这项工作揭示了在乳腺对内微环境中预防PABC进展的合理目标,对改善成千上万的年轻乳腺癌妇女的预后具有重要意义。

著录项

  • 作者

    O'Brien, Jenean H.;

  • 作者单位

    University of Colorado Health Sciences Center.;

  • 授予单位 University of Colorado Health Sciences Center.;
  • 学科 Biology Cell.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 147 p.
  • 总页数 147
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号